A bipolar disorder research ... basis for new diagnostic and treatment approaches,” Cara Altimus, Ph.D., managing director ...

Bristol Myers Squibb Co. gained US approval for the first new type of schizophrenia drug in seven decades, opening a fresh ...

Standard ALL treatment ... lasts 2 years. During the maintenance phase people often go back to work or college. If you have a stem cell or bone marrow transplant the treatment time is shorter but more ...

Oral and poster presentations of results from Study 501 evaluating lumateperone 42 mg as an adjunctive therapy to antidepressants for the ...

Recently initiated SERENITY At-Home pivotal Phase 3 trial for agitation associated with bipolar disorders or schizophrenia ...

These changes affect retirement savings plans such as 401(k), 403(b), IRA, Roth accounts, and related tax breaks. The primary objective of SECURE 2.0 is to encourage more workers to save for ...

The AMPLIFY trial will assess the safety and efficacy of ABX-002 when used alongside existing SSRI or SNRI treatments.

Controversial plans for a sewage treatment plant to serve almost 6,000 ... it was set to cost £26.2 million, but “inflationary pressures” have now raised this to £30m. Find out about ...

AMPLIFY 230-patient trial aims to improve on efficacy and safety established with thyroid hormone as an adjunctive treatment for MDD; topline data expected in ...

Ipsen canceled plans to commercialize a treatment for prostate cancer after a late-stage trial stopped short of reaching its main goals. The French pharmaceutical company said Sunday that its ...

Researchers at the University of California–San Diego calculated the ratio of time that people with bipolar 2 spend in depression versus hypomania at 40:1 ... Additionally, there are atypical ...